The global Cognitive and Memory Enhancer Drugs market was valued at US$ 4262.2 million in 2022 and is projected to reach US$ 5874.2 million by 2029, at a CAGR of 4.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Cognitive enhancers are drugs and supplements, which are majorly used to treat patients suffering from Alzheimer's disease, schizophrenia, stroke, attention deficit hyperactivity disorder, or aging.
This report aims to provide a comprehensive presentation of the global market for Cognitive and Memory Enhancer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cognitive and Memory Enhancer Drugs. This report contains market size and forecasts of Cognitive and Memory Enhancer Drugs in global, including the following market information:
- Global Cognitive and Memory Enhancer Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
In 2017, the global Cognitive and Memory Enhancer Drugs market size was 4130 million US$ and is forecast to 8030 million US in 2025, growing at a CAGR of 8.7% from 2018. The objectives of this study are to define, segment, and project the size of the Cognitive and Memory Enhancer Drugs market based on company, product type, application and key regions.
We surveyed the Cognitive and Memory Enhancer Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cognitive and Memory Enhancer Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Cognitive and Memory Enhancer Drugs Market Segment Percentages, by Type, 2022 (%)
- Aricept
- Exelon
- Namenda
- Razadyne
- Provigil
- Ritalin
- Adderall
- Others
Global Cognitive and Memory Enhancer Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Cognitive and Memory Enhancer Drugs Market Segment Percentages, by Application, 2022 (%)
- Disease Treatment
- Academic Performance
- Athletic Performance
- Others
Global Cognitive and Memory Enhancer Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Cognitive and Memory Enhancer Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cognitive and Memory Enhancer Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cognitive and Memory Enhancer Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- Eisai Co
- Allergan
- Novartis
- Takeda
- Johnson & Johnson
- Takeda Pharmaceutical Company Limited
- AlternaScript
- Cephalon
- Ceretropic
Outline of Major Chapters:
- Chapter 1: Introduces the definition of Cognitive and Memory Enhancer Drugs, market overview.
- Chapter 2: Global Cognitive and Memory Enhancer Drugs market size in revenue.
- Chapter 3: Detailed analysis of Cognitive and Memory Enhancer Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Cognitive and Memory Enhancer Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cognitive and Memory Enhancer Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cognitive and Memory Enhancer Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cognitive and Memory Enhancer Drugs Overall Market Size
2.1 Global Cognitive and Memory Enhancer Drugs Market Size: 2022 VS 2030
2.2 Global Cognitive and Memory Enhancer Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cognitive and Memory Enhancer Drugs Players in Global Market
3.2 Top Global Cognitive and Memory Enhancer Drugs Companies Ranked by Revenue
3.3 Global Cognitive and Memory Enhancer Drugs Revenue by Companies
3.4 Top 3 and Top 5 Cognitive and Memory Enhancer Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cognitive and Memory Enhancer Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cognitive and Memory Enhancer Drugs Players in Global Market
3.6.1 List of Global Tier 1 Cognitive and Memory Enhancer Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Cognitive and Memory Enhancer Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cognitive and Memory Enhancer Drugs Market Size Markets, 2022 & 2030
4.1.2 Aricept
4.1.3 Exelon
4.1.4 Namenda
4.1.5 Razadyne
4.1.6 Provigil
4.1.7 Ritalin
4.1.8 Adderall
4.1.9 Others
4.2 By Type - Global Cognitive and Memory Enhancer Drugs Revenue & Forecasts
4.2.1 By Type - Global Cognitive and Memory Enhancer Drugs Revenue, 2018-2023
4.2.2 By Type - Global Cognitive and Memory Enhancer Drugs Revenue, 2024-2030
4.2.3 By Type - Global Cognitive and Memory Enhancer Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cognitive and Memory Enhancer Drugs Market Size, 2022 & 2030
5.1.2 Disease Treatment
5.1.3 Academic Performance
5.1.4 Athletic Performance
5.1.5 Others
5.2 By Application - Global Cognitive and Memory Enhancer Drugs Revenue & Forecasts
5.2.1 By Application - Global Cognitive and Memory Enhancer Drugs Revenue, 2018-2023
5.2.2 By Application - Global Cognitive and Memory Enhancer Drugs Revenue, 2024-2030
5.2.3 By Application - Global Cognitive and Memory Enhancer Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Cognitive and Memory Enhancer Drugs Market Size, 2022 & 2030
6.2 By Region - Global Cognitive and Memory Enhancer Drugs Revenue & Forecasts
6.2.1 By Region - Global Cognitive and Memory Enhancer Drugs Revenue, 2018-2023
6.2.2 By Region - Global Cognitive and Memory Enhancer Drugs Revenue, 2024-2030
6.2.3 By Region - Global Cognitive and Memory Enhancer Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Cognitive and Memory Enhancer Drugs Revenue, 2018-2030
6.3.2 US Cognitive and Memory Enhancer Drugs Market Size, 2018-2030
6.3.3 Canada Cognitive and Memory Enhancer Drugs Market Size, 2018-2030
6.3.4 Mexico Cognitive and Memory Enhancer Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Cognitive and Memory Enhancer Drugs Revenue, 2018-2030
6.4.2 Germany Cognitive and Memory Enhancer Drugs Market Size, 2018-2030
6.4.3 France Cognitive and Memory Enhancer Drugs Market Size, 2018-2030
6.4.4 U.K. Cognitive and Memory Enhancer Drugs Market Size, 2018-2030
6.4.5 Italy Cognitive and Memory Enhancer Drugs Market Size, 2018-2030
6.4.6 Russia Cognitive and Memory Enhancer Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Cognitive and Memory Enhancer Drugs Market Size, 2018-2030
6.4.8 Benelux Cognitive and Memory Enhancer Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Cognitive and Memory Enhancer Drugs Revenue, 2018-2030
6.5.2 China Cognitive and Memory Enhancer Drugs Market Size, 2018-2030
6.5.3 Japan Cognitive and Memory Enhancer Drugs Market Size, 2018-2030
6.5.4 South Korea Cognitive and Memory Enhancer Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Cognitive and Memory Enhancer Drugs Market Size, 2018-2030
6.5.6 India Cognitive and Memory Enhancer Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Cognitive and Memory Enhancer Drugs Revenue, 2018-2030
6.6.2 Brazil Cognitive and Memory Enhancer Drugs Market Size, 2018-2030
6.6.3 Argentina Cognitive and Memory Enhancer Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cognitive and Memory Enhancer Drugs Revenue, 2018-2030
6.7.2 Turkey Cognitive and Memory Enhancer Drugs Market Size, 2018-2030
6.7.3 Israel Cognitive and Memory Enhancer Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Cognitive and Memory Enhancer Drugs Market Size, 2018-2030
6.7.5 UAE Cognitive and Memory Enhancer Drugs Market Size, 2018-2030
7 Cognitive and Memory Enhancer Drugs Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Cognitive and Memory Enhancer Drugs Major Product Offerings
7.1.4 Pfizer Cognitive and Memory Enhancer Drugs Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Eisai Co
7.2.1 Eisai Co Company Summary
7.2.2 Eisai Co Business Overview
7.2.3 Eisai Co Cognitive and Memory Enhancer Drugs Major Product Offerings
7.2.4 Eisai Co Cognitive and Memory Enhancer Drugs Revenue in Global Market (2018-2023)
7.2.5 Eisai Co Key News & Latest Developments
7.3 Allergan
7.3.1 Allergan Company Summary
7.3.2 Allergan Business Overview
7.3.3 Allergan Cognitive and Memory Enhancer Drugs Major Product Offerings
7.3.4 Allergan Cognitive and Memory Enhancer Drugs Revenue in Global Market (2018-2023)
7.3.5 Allergan Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Cognitive and Memory Enhancer Drugs Major Product Offerings
7.4.4 Novartis Cognitive and Memory Enhancer Drugs Revenue in Global Market (2018-2023)
7.4.5 Novartis Key News & Latest Developments
7.5 Takeda
7.5.1 Takeda Company Summary
7.5.2 Takeda Business Overview
7.5.3 Takeda Cognitive and Memory Enhancer Drugs Major Product Offerings
7.5.4 Takeda Cognitive and Memory Enhancer Drugs Revenue in Global Market (2018-2023)
7.5.5 Takeda Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Cognitive and Memory Enhancer Drugs Major Product Offerings
7.6.4 Johnson & Johnson Cognitive and Memory Enhancer Drugs Revenue in Global Market (2018-2023)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 Takeda Pharmaceutical Company Limited
7.7.1 Takeda Pharmaceutical Company Limited Company Summary
7.7.2 Takeda Pharmaceutical Company Limited Business Overview
7.7.3 Takeda Pharmaceutical Company Limited Cognitive and Memory Enhancer Drugs Major Product Offerings
7.7.4 Takeda Pharmaceutical Company Limited Cognitive and Memory Enhancer Drugs Revenue in Global Market (2018-2023)
7.7.5 Takeda Pharmaceutical Company Limited Key News & Latest Developments
7.8 AlternaScript
7.8.1 AlternaScript Company Summary
7.8.2 AlternaScript Business Overview
7.8.3 AlternaScript Cognitive and Memory Enhancer Drugs Major Product Offerings
7.8.4 AlternaScript Cognitive and Memory Enhancer Drugs Revenue in Global Market (2018-2023)
7.8.5 AlternaScript Key News & Latest Developments
7.9 Cephalon
7.9.1 Cephalon Company Summary
7.9.2 Cephalon Business Overview
7.9.3 Cephalon Cognitive and Memory Enhancer Drugs Major Product Offerings
7.9.4 Cephalon Cognitive and Memory Enhancer Drugs Revenue in Global Market (2018-2023)
7.9.5 Cephalon Key News & Latest Developments
7.10 Ceretropic
7.10.1 Ceretropic Company Summary
7.10.2 Ceretropic Business Overview
7.10.3 Ceretropic Cognitive and Memory Enhancer Drugs Major Product Offerings
7.10.4 Ceretropic Cognitive and Memory Enhancer Drugs Revenue in Global Market (2018-2023)
7.10.5 Ceretropic Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cognitive and Memory Enhancer Drugs Market Opportunities & Trends in Global Market
Table 2. Cognitive and Memory Enhancer Drugs Market Drivers in Global Market
Table 3. Cognitive and Memory Enhancer Drugs Market Restraints in Global Market
Table 4. Key Players of Cognitive and Memory Enhancer Drugs in Global Market
Table 5. Top Cognitive and Memory Enhancer Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cognitive and Memory Enhancer Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cognitive and Memory Enhancer Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cognitive and Memory Enhancer Drugs Product Type
Table 9. List of Global Tier 1 Cognitive and Memory Enhancer Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cognitive and Memory Enhancer Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Cognitive and Memory Enhancer Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cognitive and Memory Enhancer Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Cognitive and Memory Enhancer Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cognitive and Memory Enhancer Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Cognitive and Memory Enhancer Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cognitive and Memory Enhancer Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Pfizer Company Summary
Table 31. Pfizer Cognitive and Memory Enhancer Drugs Product Offerings
Table 32. Pfizer Cognitive and Memory Enhancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Eisai Co Company Summary
Table 35. Eisai Co Cognitive and Memory Enhancer Drugs Product Offerings
Table 36. Eisai Co Cognitive and Memory Enhancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Eisai Co Key News & Latest Developments
Table 38. Allergan Company Summary
Table 39. Allergan Cognitive and Memory Enhancer Drugs Product Offerings
Table 40. Allergan Cognitive and Memory Enhancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Allergan Key News & Latest Developments
Table 42. Novartis Company Summary
Table 43. Novartis Cognitive and Memory Enhancer Drugs Product Offerings
Table 44. Novartis Cognitive and Memory Enhancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Novartis Key News & Latest Developments
Table 46. Takeda Company Summary
Table 47. Takeda Cognitive and Memory Enhancer Drugs Product Offerings
Table 48. Takeda Cognitive and Memory Enhancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Takeda Key News & Latest Developments
Table 50. Johnson & Johnson Company Summary
Table 51. Johnson & Johnson Cognitive and Memory Enhancer Drugs Product Offerings
Table 52. Johnson & Johnson Cognitive and Memory Enhancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Johnson & Johnson Key News & Latest Developments
Table 54. Takeda Pharmaceutical Company Limited Company Summary
Table 55. Takeda Pharmaceutical Company Limited Cognitive and Memory Enhancer Drugs Product Offerings
Table 56. Takeda Pharmaceutical Company Limited Cognitive and Memory Enhancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Takeda Pharmaceutical Company Limited Key News & Latest Developments
Table 58. AlternaScript Company Summary
Table 59. AlternaScript Cognitive and Memory Enhancer Drugs Product Offerings
Table 60. AlternaScript Cognitive and Memory Enhancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. AlternaScript Key News & Latest Developments
Table 62. Cephalon Company Summary
Table 63. Cephalon Cognitive and Memory Enhancer Drugs Product Offerings
Table 64. Cephalon Cognitive and Memory Enhancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Cephalon Key News & Latest Developments
Table 66. Ceretropic Company Summary
Table 67. Ceretropic Cognitive and Memory Enhancer Drugs Product Offerings
Table 68. Ceretropic Cognitive and Memory Enhancer Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Ceretropic Key News & Latest Developments
List of Figures
Figure 1. Cognitive and Memory Enhancer Drugs Segment by Type in 2022
Figure 2. Cognitive and Memory Enhancer Drugs Segment by Application in 2022
Figure 3. Global Cognitive and Memory Enhancer Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cognitive and Memory Enhancer Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Cognitive and Memory Enhancer Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cognitive and Memory Enhancer Drugs Revenue in 2022
Figure 8. By Type - Global Cognitive and Memory Enhancer Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Cognitive and Memory Enhancer Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Cognitive and Memory Enhancer Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Cognitive and Memory Enhancer Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Cognitive and Memory Enhancer Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Cognitive and Memory Enhancer Drugs Revenue Market Share, 2018-2030
Figure 16. US Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Cognitive and Memory Enhancer Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Cognitive and Memory Enhancer Drugs Revenue Market Share, 2018-2030
Figure 28. China Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Cognitive and Memory Enhancer Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Cognitive and Memory Enhancer Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Cognitive and Memory Enhancer Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Pfizer Cognitive and Memory Enhancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Eisai Co Cognitive and Memory Enhancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Allergan Cognitive and Memory Enhancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Novartis Cognitive and Memory Enhancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Takeda Cognitive and Memory Enhancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Johnson & Johnson Cognitive and Memory Enhancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Takeda Pharmaceutical Company Limited Cognitive and Memory Enhancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. AlternaScript Cognitive and Memory Enhancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Cephalon Cognitive and Memory Enhancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Ceretropic Cognitive and Memory Enhancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
